BRUSSELS (Reuters) - Newly listed heart drug firm Cardio3 said on Tuesday that questions raised in Forbes magazine over research on its leading product were unfounded.
Source:
http://www.sporttrainer.cc/cardio3-says-questions-over-heart-drug-research-are-unfounded/?utm_source=rss&utm_medium=rss&utm_campaign=cardio3-says-questions-over-heart-drug-research-are-unfounded